SDM - News

2025-10-28

Jing Medicine's Next-Generation EGFR PROTAC Program Clears U.S. FDA for Clinical Trials | Backed by SDM

SDM Bioservices, serving as Jing Medicine’s regulatory strategy partner, played a pivotal role in the successful FDA application process. Leveraging deep expertise in global regulatory affairs, SDM delivered comprehensive GAP analysis, technical document preparation, and submission management services. SDM also supported Jing Medicine’s IND application in China, establishing a robust foundation for the program’s global development strategy.

MORE >

2025-10-14

Dr. Weishihu Joins SDM as Deputy General Manager of Medical & Pharmacovigilance for Early Clinical Business Unit

Beijing, October 14, 2025 – SDM, a one-stop clinical development CRO, today announced that Dr. Weishihu has joined the company as Deputy General Manager of Medical and Pharmacovigilance for the Early Clinical Business Unit. He will be fully responsible for developing and managing the company's early clinical development medical strategies and pharmacovigilance systems.

MORE >

2025-09-12

Combine the Strength and Forge Ahead Together! - SDM Clinical Operations & SMO Alignment Workshop

On September 6-7, 2025, SDM’s Clinical Operations and SMO teams come together at the 21st Century Tower in Beijing for an alignment workshop. Focused on “unifying our approach and enhancing collaboration,” the two-day event tackled key integration points between project and talent management. Through focused discussions, we turned consensus into actionable plans, established standardized workflows, and built cross-functional synergy-all strengthening SDM’s foundation to position SDM a higher-quality CRO to better serve clients and patients.

MORE >

2025-07-24

SDM Bioservices Collaborates with Leading Experts to Discuss Innovation in Drug Development and Accelerated Approval Pathways

The seminar attracted representatives from nearly 30 pharmaceutical companies in the Sichuan-Chongqing region, injecting new momentum into the regional biopharmaceutical innovation ecosystem.

MORE >

2025-06-13

SDM Bioservices Successfully Hosts Closed-Door Workshop on "The Power of Quantitative Pharmacology"

Dr. Wang delivered a keynote presentation titled "The Power of Quantitative Pharmacology: Critical Insights from Landmark Clinical Development and Regulatory Cases," providing an in-depth analysis of the central role of quantitative pharmacology across the entire clinical development lifecycle of investigational drugs.

MORE >

News

News

Jing Medicine's Next-Generation EGFR PROTAC Program Clears U.S. FDA for Clinical Trials | Backed by SDM

Dr. Weishihu Joins SDM as Deputy General Manager of Medical & Pharmacovigilance for Early Clinical Business Unit

Combine the Strength and Forge Ahead Together! - SDM Clinical Operations & SMO Alignment Workshop

SDM Bioservices Collaborates with Leading Experts to Discuss Innovation in Drug Development and Accelerated Approval Pathways

SDM Bioservices Successfully Hosts Closed-Door Workshop on "The Power of Quantitative Pharmacology"

Last Name：